Cart
sales@molnova.com
(±) Clopidogrel hydrogensulfate
CAS No. 135046-48-9
(±) Clopidogrel hydrogensulfate( —— )
Catalog No. M11416 CAS No. 135046-48-9
Clopidogrel, an antiplatelet agent structurally and pharmacologically similar to ticlopidine.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 29 | In Stock |
|
| 50MG | 34 | In Stock |
|
| 100MG | 47 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 105 | In Stock |
|
| 1G | 152 | In Stock |
|
Biological Information
-
Product Name(±) Clopidogrel hydrogensulfate
-
NoteResearch use only, not for human use.
-
Brief DescriptionClopidogrel, an antiplatelet agent structurally and pharmacologically similar to ticlopidine.
-
DescriptionClopidogrel, an antiplatelet agent structurally and pharmacologically similar to ticlopidine, is used to inhibit blood clots in a variety of conditions such as peripheral vascular disease, coronary artery disease, and cerebrovascular disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNeuroscience
-
TargetP2 Receptor
-
RecptorP2Y12
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number135046-48-9
-
Formula Weight419.9
-
Molecular FormulaC16H16ClNO2S · H2SO4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCOC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dorsam RT, et al. Hematology. 2003 Dec;8(6):359-65.
molnova catalog
related products
-
A-317491
A-317491 is a non-nucleotide P2X3 ( Ki: 22 nM) and P2X2/3 receptor (Ki: 9 nM) antagonist, which inhibits calcium flux mediated by the receptors.
-
PSB-12062
PSB-12062 is a potent and selective antagonist of P2X4(IC50 of 1.38 μM for human P2X4). PSB-12062 is ?a selective P2X4 antagonist that was equally potent in all three species (IC(50): 0.928-1.76 μM).?The compounds showed an allosteric mechanism of action.?
-
TAPI-1 trifluoroacet...
TAPI-1 is an ADAM17/TACE inhibitor, which blocks shedding of cytokine receptors.
